BXRX - Baudax Bio, Inc.

0.18
0.180   100.000%

Share volume: 0
Last Updated: 11-15-2023

PREVIOUS CLOSE
CHG
CHG%
N/A
0.00
0.00%
This ticker is disabled and data are no longer maintained and up to date.
Overview Charts Historical prices Events Documents Notes Dividends
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
0   0%
1 Month
0   0%
3 Months
0   0%
6 Months
-100.00%
1 Year
-100.00%
2 Year
-100.00%
Key data
Stock price
$0.18
P/E Ratio 
0.00
DAY RANGE
N/A - N/A
EPS 
-$16.69
52 WEEK RANGE
$0.00 - $0.02
52 WEEK CHANGE
-$100.00
MARKET CAP 
0.000
YIELD 
N/A
SHARES OUTSTANDING 
52.460 M
DIVIDEND
$0.00
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
N/A
BETA 
0.00
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
N/A
AVERAGE 30 VOLUME 
N/A
Company detail
CEO: Gerri A. Henwood
Region: US
Website: baudaxbio.com
Employees: 9
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry:
Sector:

Baudax Bio, Inc. develops and commercializes products for hospital and other acute care settings. The company offers ANJESO (meloxicam) injection for management of moderate to severe pain, alone or in combination with non-NSAID analgesics. Its products under development includes BX1000, an intermediate-acting neuromuscular blocking agent (NMB)

Recent news